New Zealand markets open in 7 hours 57 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
460.78+4.46 (+0.98%)
At close: 04:04PM EDT
460.78 +0.23 (+0.05%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.82B
Enterprise value 13.42B
Trailing P/E N/A
Forward P/E 29.33
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)4.97
Price/book (mrq)1.44
Enterprise value/revenue 4.79
Enterprise value/EBITDA -2.96

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-19.74%
S&P500 52-week change 3-13.21%
52-week high 3607.54
52-week low 3344.63
50-day moving average 3472.67
200-day moving average 3459.43

Share statistics

Avg vol (3-month) 3171.6k
Avg vol (10-day) 3192.36k
Shares outstanding 524.52M
Implied shares outstanding 6N/A
Float 821.1M
% held by insiders 114.54%
% held by institutions 180.37%
Shares short (14 Mar 2023) 4362.44k
Short ratio (14 Mar 2023) 41.69
Short % of float (14 Mar 2023) 41.73%
Short % of shares outstanding (14 Mar 2023) 41.22%
Shares short (prior month 14 Feb 2023) 4245.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin -129.45%
Operating margin (ttm)17.38%

Management effectiveness

Return on assets (ttm)1.94%
Return on equity (ttm)-31.14%

Income statement

Revenue (ttm)2.8B
Revenue per share (ttm)94.08
Quarterly revenue growth (yoy)-0.30%
Gross profit (ttm)1.57B
EBITDA 624.22M
Net income avi to common (ttm)-3.63B
Diluted EPS (ttm)-120.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.79B
Total cash per share (mrq)60.5
Total debt (mrq)1.39B
Total debt/equity (mrq)14.44
Current ratio (mrq)5.55
Book value per share (mrq)324.89

Cash flow statement

Operating cash flow (ttm)194.4M
Levered free cash flow (ttm)45.59M